Company Profile

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

Latest News

Ipsen’s Bylvay fails in Phase III biliary atresia study

Clinical Trials Arena • 07/27/2026

Rothschild & Co Redburn Adjusts PT on Honeywell International to $216 From $214, Keeps Neutral Rating

MT Newswires • 07/27/2026

JPMorgan Adjusts PT on Honeywell International to $262 From $250, Maintains Overweight Rating

MT Newswires • 07/27/2026

Jefferies Adjusts Price Target on Teledyne Technologies to $830 From $775, Maintains Buy Rating

MT Newswires • 07/27/2026

Goldman Sachs Adjusts PT on Teledyne Technologies to $877 From $858, Maintains Buy Rating

MT Newswires • 07/27/2026